Abstract
Objectives Maternal hypertensive disorders (MHD) are widespread globally, modifying maternal and fetal immunity, and have been linked to increased allergic diseases in offsprings. Nevertheless, so far, most studies in this field are small-scale and results remain inconclusive.
Methods Harnessing unprecedented global allergic disease and pregnancy data covering more than 150 countries from 1990 to 2019 as proxies, we leveraged the state-of-the-art generalized additive model (GAM) to interrogate the potential link between MHD and common offspring allergic diseases, exemplified by atopic dermatitis (AD) and asthma.
Results A model considering the main effects from MHD, socioeconomic factor like GDP and time, as well as their interactions was favoured, suggesting their interactive effects on offspring allergic diseases. Generally, MHD in pregnancies were associated with increased AD and asthma in offsprings early in life, and a more pronounced effect was found for AD relative to asthma.
Conclusions Globally, MHD in pregnancies are linked to increased offspring allergic disease burden, which, with further in-depth investigations, would inform allergic disease preventions in clinic. Our analyses also support the Developmental Origins of Health and Disease (DOHAD) concept and showcase a novel methodology for DOHAD-related research.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project is supported by the Norman Ernest Bequest Fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors